SWP
BBH icon

Stratos Wealth Partners’s VanEck Biotech ETF BBH Stock Holding History

Stratos Wealth Partners’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-45
Closed -$6K – 970
2018
Q3 		$6K Buy
+45
New +$5.85K ﹤0.01% 2360
2018
Q2 		– Sell
-45
Closed -$5K – 1108
2018
Q1 		$5K Sell
45
-2,132
-98% -$268K ﹤0.01% 2589
2017
Q4 		$271K Sell
2,177
-27
-1% -$3.45K 0.01% 744
2017
Q3 		$296K Buy
2,204
+117
+6% +$15.2K 0.01% 694
2017
Q2 		$262K Buy
2,087
+43
+2% +$5.18K 0.01% 683
2017
Q1 		$243K Sell
2,044
-30
-1% -$3.51K 0.01% 651
2016
Q4 		$223K Buy
+2,074
New +$226K 0.01% 623

Other funds holding BBH

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Stratos Wealth Partners's BBH Position: Q4 2018 in Review

Stratos Wealth Partners sold out of VanEck Biotech ETF (BBH) in Q4 2018, closing a stake of 45 shares — an estimated $6K sold.

Stratos Wealth Partners first reported a position in BBH in Q4 2016 and held it in 7 quarters. The position peaked at $296K in Q3 2017. 84 funds tracked by Wall St. Rank hold BBH as of Q4 2018.

  • Stratos Wealth Partners reported no remaining VanEck Biotech ETF position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 45 VanEck Biotech ETF shares in Q4 2018, an estimated $6K.
  • Stratos Wealth Partners first reported a position in VanEck Biotech ETF in Q4 2016 and held it in 7 quarters.
  • Stratos Wealth Partners's VanEck Biotech ETF position peaked at $296K in Q3 2017.
  • 84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.